Age-related macular degeneration: current treatments

Age-related macular degeneration: current treatments

PURPOSE Although important progress has been made in understanding age-related macular degeneration (AMD), management of the disease continues to be a challenge. AMD research has led to a widening of available treatment options and improved prognostic perspectives. This essay reviews these treatment options. DESIGN Interpretative essay. METHODS Literature review and interpretation. RESULT...

New treatments in age-related macular degeneration.

Age-related macular degeneration (AMD) is the leading cause of legal blindness in individuals 50 years and older in the developed world. Choroidal neovascularization (CNV) in exudative AMD is responsible for the majority of severe vision loss. Until recently, laser photocoagulation was the only well-established and widely accepted treatment for CNV. However, it is beneficial only for a small su...

بررسی اثر چندشکلی ژنتیکی xrcc7 با ریسک ابتلا به بیماریamd age-related macular degeneration))

amd بیماری تحلیل شبکیه است که عامل اصلی کوری در افراد بالای 55 سال در جهان غرب به شمار می-رود. در اثر این بیماری، لیپوپروتئین ها در شبکیه تجمع پیدا کرده و رگ زایی القاء می شود. ثابت شده است که عوامل ژنوتوکسیک محیطی مثل سیگار کشیدن، رژیم غذایی و نور در افراد پیر با زمینه ی ژنتیکی مستعد در بروز بیماری دخیل می باشند. بنابراین ما یک مطالعه ی مـورد- شاهـدی را ترتیب دادیم که شـامل 112 فرد مبتلا به am...

Experimental Treatments for Neovascular Age-Related Macular Degeneration

Clinical update: new treatments for age-related macular degeneration.

Age-related macular degeneration (AMD) is the leading cause of vision loss in the developed world. Until recently, this condition was believed to be largely untreatable, but developments in the past 2 years have challenged this view. A new class of drugs—based on suppression of vascular endothelial growth factor (VEGF)—has been introduced for the treatment of “wet” or neovascular AMD, the most ...